High Levels of Drug‐Resistant Human Immunodeficiency Virus Variants in Patients Exhibiting Increasing CD4+T Cell Counts Despite Virologic Failure of Protease Inhibitor–Containing Antiretroviral Combination Therapy

MLA

Christophe Piketty, et al. “High Levels of Drug‐Resistant Human Immunodeficiency Virus Variants in Patients Exhibiting Increasing CD4+T Cell Counts Despite Virologic Failure of Protease Inhibitor–Containing Antiretroviral Combination Therapy.” The Journal of Infectious Diseases, vol. 181, May 2000, pp. 1808–12. EBSCOhost, https://doi.org/10.1086/315429.

APA

Christophe Piketty, Laurence Weiss, Christophe Goujon, Ali Si-Mohamed, Michel D. Kazatchkine, Sylvie Cotigny, Laurent Bélec, & Marie-Charlotte Hallouin. (2000). High Levels of Drug‐Resistant Human Immunodeficiency Virus Variants in Patients Exhibiting Increasing CD4+T Cell Counts Despite Virologic Failure of Protease Inhibitor–Containing Antiretroviral Combination Therapy. The Journal of Infectious Diseases, 181, 1808–1812. https://doi.org/10.1086/315429

Chicago

Christophe Piketty, Laurence Weiss, Christophe Goujon, Ali Si-Mohamed, Michel D. Kazatchkine, Sylvie Cotigny, Laurent Bélec, and Marie-Charlotte Hallouin. 2000. “High Levels of Drug‐Resistant Human Immunodeficiency Virus Variants in Patients Exhibiting Increasing CD4+T Cell Counts Despite Virologic Failure of Protease Inhibitor–Containing Antiretroviral Combination Therapy.” The Journal of Infectious Diseases 181 (May): 1808–12. doi:10.1086/315429.